🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Status
Completed
Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Start Date
2022-07-05
Trial ID
NCT05415215
This study is the study of the combination of PEGPH20 and Pembrolizumab (MK...
Status
Unknown
Location
Banner Health - MD Anderson Cancer Center
Start Date
2019-05-01
Trial ID
NCT03634332
Treatments Being Tested
This was a prospective, multicenter, open label extension (OLE) trial on th...
Status
Terminated
Location
Investigator site 115 - US0010086
Start Date
2021-07-15
Trial ID
NCT04598477
Treatments Being Tested
This is a prospective, multicenter, randomized, double-blinded, placebo-con...
Status
Completed
Location
Investigator site 77 - US0010086
Start Date
2020-12-01
Trial ID
NCT04598451
Treatments Being Tested
The purpose of this study is to evaluate the safety of efgartigimod PH20 SC...
Status
Terminated
Location
Medical Dermatology Specialists
Start Date
2023-03-22
Trial ID
NCT05681481
Treatments Being Tested
This study's purpose is to measure the treatment response from efgartigimod...
Status
Completed
Location
Neuromuscular Research Center
Start Date
2022-10-12
Trial ID
NCT05523167
Treatments Being Tested
ARGX-113-2009 is an operationally seamless 2-part, phase 2/3, prospective, ...
Status
Completed
Location
Investigator site 74 - US0010178
Start Date
2022-06-09
Trial ID
NCT05267600
Treatments Being Tested
This phase II trial studies how well pembrolizumab and PEGPH20 work in trea...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2020-02-01
Trial ID
NCT04058964
Treatments Being Tested
An open-label, two part study to assess the safety, tolerability, and PK of...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-23
Trial ID
NCT05291520
This Phase III, randomized, two-arm, open-label, multicenter study will eva...
Status
Active Not Recruiting
Location
Arizona Clinical Research Center, Inc
Start Date
2022-07-18
Trial ID
NCT05296798